Detalhe da pesquisa
1.
Implementing Genome-Driven Oncology.
Cell
; 168(4): 584-599, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187282
2.
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 577(7789): E1, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822847
3.
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
N Engl J Med
; 386(8): 735-743, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196427
4.
A view on drug resistance in cancer.
Nature
; 575(7782): 299-309, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31723286
5.
Efficacy of MEK inhibition in patients with histiocytic neoplasms.
Nature
; 567(7749): 521-524, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867592
6.
Tumour lineage shapes BRCA-mediated phenotypes.
Nature
; 571(7766): 576-579, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292550
7.
Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Nature
; 566(7745): E11-E12, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30755741
8.
HER kinase inhibition in patients with HER2- and HER3-mutant cancers.
Nature
; 554(7691): 189-194, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420467
9.
Small molecules, big impact: 20 years of targeted therapy in oncology.
Lancet
; 395(10229): 1078-1088, 2020 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222192
10.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466156
11.
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
Lancet Oncol
; 21(4): 531-540, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105622
12.
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Cancer
; 126(6): 1274-1282, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880826
13.
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.
Cancer
; 126(22): 4967-4974, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32809222
14.
Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Annu Rev Med
; 69: 319-331, 2018 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29120700
15.
Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT.
Radiology
; 296(2): 370-378, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515679
16.
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Mod Pathol
; 33(1): 38-46, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375766
17.
Correction to: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer.
Ann Surg Oncol
; 27(Suppl 3): 963, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898094
18.
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 159(1): 150-156, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723675
19.
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecol Oncol
; 156(1): 194-202, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757464
20.
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 20(5): 711-718, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922731